Results 151 to 160 of about 831,586 (304)

A Case of Clinically Suspected Kounis Syndrome Associated with Platelet Transfusion during Thoracoscopic Right Lower Lobectomy. [PDF]

Surg Case Rep
Baba T, Inokawa H, Okada M, Okita R.
europepmc   +1 more source

Neutrophil extracellular traps induced by activated platelets as a cause of neutrophil–platelet aggregation in β‐thalassaemia/haemoglobin E patients

British Journal of Haematology, EarlyView.
Abnormal neutrophils and platelets in splenectomised β‐thalassaemia/haemoglobin E (HbE) disease contribute to neutrophil–platelet aggregation, leading to a high risk of thrombus formation. Activated platelets induce neutrophils to generate neutrophil extracellular trap (NETs) via the P‐selectin–P‐selectin glycoprotein ligand‐1 (PSGL1) pathway, which ...
Rattanawan Thubthed, Rattanaporn Praneetponkang, Potchaman Sittipaisankul, Chayada Thiengtavor, Suwathida Chumpuchanaphai, Kittiphong Paiboonsukwong, Suthat Fucharoen, Kovit Pattanapanyasat, Jim Vadolas, Duncan R. Smith, Saovaros Svasti, Pornthip Chaichompoo   +11 more
wiley   +1 more source

Platelet transfusion in end-of-life adult care. [PDF]

Hematol Transfus Cell Ther
Cibele D, Trigo F, Barbosa M, Almeida J, Paiva JA, Gonçalves E, Brito J, Teixeira J, Araújo F.   +8 more
europepmc   +1 more source

Clinical and immunological effects of adding cyclophosphamide to pomalidomide–dexamethasone in relapsed‐refractory multiple myeloma: The randomized MUKseven trial

British Journal of Haematology, EarlyView.
Summary There is an ongoing need for accessible combination therapies for patients with relapsed‐refractory multiple myeloma (RRMM), alongside a growing interest in understanding their immunological effects, particularly on T‐cell populations. Myeloma UK (MUK) MUKseven (NCT02406222) was an academic, UK multicentre randomized controlled, open‐label ...
Andrew Hall, James Croft, Katrina Walker, Kevin Boyd, Sadie Roberts, Amy Holroyd, Mamta Garg, Elsa Ferris, Gordon Cook, William E. Pierceall, Anjan Thakurta, Anita Gandhi, Charlotte Pawlyn, Sarah R. Brown, Martin Kaiser   +14 more
wiley   +1 more source

Hemostatic rescue with rFVIIa in Bernard-Soulier syndrome refractory to HLA-matched platelet transfusion. [PDF]

Ann Hematol
Okamoto Y, Mizumoto C, Yamashita K, Inoue S, Saito S, Morimoto N, Takaori-Kondo A.   +6 more
europepmc   +1 more source

Hydroxyurea (hydroxycarbamide) use in adults with haemoglobin SC disease: A real‐world study in Quebec

British Journal of Haematology, EarlyView.
Summary Haemoglobin SC (HbSC) disease is the second most prevalent form of sickle cell disease, but evidence for hydroxyurea (hydroxycarbamide; HU) to prevent pain episodes was limited until the prospective identification of variables as outcomes for treatment (PIVOT) trial.
Alice Girard, Laurianne Charette, Mélissa Haouchine, Laurence Bozec, Mohamed Zakaria Bachir Bouyadjera, Mariane Poitras, Vincent‐Thierry Taillefer, Chloé Trudeau, Yves Pastore, Nathalie Letarte, Stéphanie Forté   +10 more
wiley   +1 more source

Patient Blood Management in Hematology: Focusing on Platelet Transfusion. [PDF]

J Clin Med
Solves P, Córcoles M, Soriano M, Lamas B, Martínez-Campuzano D, Asensi P, Gómez-Seguí I, de la Rubia J.   +7 more
europepmc   +1 more source

Platelet transfusion practice in the intensive care unit: the Nine-I international platelet transfusion survey. [PDF]

Ann Intensive Care
Russell L, Azoulay E, Anthon CT, Pène F, Akella P, Mabrouki A, Puxty K, Nielsen LB, Andreasen JB, Kander T, Sjövall F, Hästbacka J, Hvas CL, Van De Louw A, Chawla S, Bauer PR, Castro P, Povoa P, Coelho L, Fernandez S, Topeli A, Barratt-Due A, Barbaglio C, Kochanek M, Martin-Loeches I, Kentish-Barnes N.   +25 more
europepmc   +1 more source

Integrating novel therapeutic strategies in myeloproliferative neoplasms: Driving disease‐directed progress

British Journal of Haematology, EarlyView.
Summary Over the past decade, there has been a substantial increase in the diversity and number of therapeutic options for myeloproliferative neoplasms (MPNs). While many remain within the clinical trial arena, the clinician and patient community have seen more approvals reaching the clinic and a rethink on how best we should be approaching these ...
Trung Q. Ngo, Maria Georgiou, Donal P. McLornan, Claire N. Harrison   +3 more
wiley   +1 more source

Postresuscitation platelet transfusion in major trauma patients. [PDF]

Transfusion
Rossetto A, Reynolds J, Ykema E, Davenport R, Cole E, Vulliamy P.   +5 more
europepmc   +1 more source